Evidence map›Paper›PMID 35365771›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022

High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.

Klaus Hirschbühl, Tina Schaller, Bruno Märkl, Rainer Claus, Eva Sipos, Lukas Rentschler, Andrea Maccagno, Bianca Grosser, Elisabeth Kling, Michael Neidig and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Coronavirus disease 2019 and lung cancer: where are we?Exploration of targeted anti-tumor therapy · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Klaus Hirschbühl *Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Tina Schaller *General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Bruno MärklGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany. bruno.maerkl@uka-science.de.ORCID 0000-0002-7704-850X
Rainer ClausHematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Eva SiposGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Lukas RentschlerGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Andrea MaccagnoGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Bianca GrosserGeneral Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Elisabeth KlingMicrobiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Michael NeidigMedical Clinic, University Hospital Augsburg, Augsburg, Germany.
Thomas KrönckeDiagnostic and Interventional Radiology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Oliver SpringAnesthesiology and Operative Intensive Care Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
Georg BraunGastroenterology, Medical Faculty, University of Augsburg, Augsburg, Germany.
Hans BösmüllerInstitute for Pathology and Neuropathology, University Hospital of Tübingen, Tübingen, Germany.
Maximilian SeidlInstitute of Pathology, University of Düsseldorf, Düsseldorf, Germany.
Irene EspositoInstitute of Pathology, University of Düsseldorf, Düsseldorf, Germany.
Jessica PablikDepartment of Pathology, Technische Universität Dresden, Dresden, Germany.
Julia HilsenbeckDepartment of Pathology, Technische Universität Dresden, Dresden, Germany.
Peter BoorInstitute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Martin BeerInstitute of Diagnostic Virology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany. martin.beer@fli.de.ORCID 0000-0002-0598-5254
Sebastian Dintner *General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Claudia Wylezich *Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.ORCID 0000-0002-0436-4480
University of Augsburg · DEFriedrich-Loeffler-Institut · DEHeinrich Heine University Düsseldorf · DETechnische Universität Dresden · DEUniversitätsklinikum Aachen · DEUniversity Children's Hospital Tübingen · DEUniversity Hospital Augsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rate of SARS-CoV-2 infections in vaccinees has become a relevant serious issue. This study aimed to determine the causes of death, histological organ alteration, and viral spread in relation to demographic, clinical-pathological, viral variants, and vaccine types for deceased individuals with proven SARS-CoV-2 infection after vaccination who died between January and November 2021. Twenty-nine consecutively collected cases were analyzed and compared to 141 nonvaccinated control cases. Autopsies were performed on 16 partially and 13 fully vaccinated individuals. Most patients were elderly and suffered from several relevant comorbidities. Real-time RT-PCR (RT-qPCR) identified a significantly increased rate of generalized viral dissemination within organ systems in vaccinated cases versus nonvaccinated cases (45% vs. 16%, respectively; P = 0.008) mainly with Ct-values of higher than 25 in non-respiratory samples. However, vaccinated cases also showed high viral loads, reaching Ct-values below 10, especially in the upper airways and lungs. This was accompanied by high rates of pulmonal bacterial or mycotic superinfections and the occurrence of immunocompromising factors, such as malignancies, immunosuppressive drug intake, or decreased immunoglobulin levels. All these findings were particularly accentuated in partially vaccinated patients compared to fully vaccinated individuals. The virus dissemination observed in our case study may indicate that patients with an impaired immune system have a decreased ability to eliminate the virus. However, the potential role of antibody-dependent enhancement must also be ruled out in future studies. Fatal cases of COVID-19 in vaccinees were rare and often associated with severe comorbidities or other immunosuppressive conditions.

Indexed as

COVID-19AgedAutopsyHumansReal-Time Polymerase Chain ReactionSARS-CoV-2Viral Load

Identifiers

PMID35365771
PMCPMC8974809
OpenAlexW4226359171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.